The effect of prostaglandin I2 analogue on diabetic nephropathy in diabetic patients with peripheral arterial disease
Not Applicable
- Conditions
- Diabetic nephropathy
- Registration Number
- JPRN-UMIN000010035
- Lead Sponsor
- ippon Medical School Department of Medicine Division of Cardiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Previous administration of pioglitazone or DPP-4 inhibitor as an oral hypoglycemic drug 2) 8.0% more than fasting HbA1c 3) Patients with proliferative diabetic retinopathy 4) Patients with bleeding tendency 5) Severe hepatopathy/nephropathy or heart disease that may affect the evaluation of drug safety 6) Patients who are deemed to be inappropriate by the investigator or sub-investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Creatinine, eGFR, cystatin C
- Secondary Outcome Measures
Name Time Method